Source: International Congress 2014 – COPD - from biomarkers to novel therapeutic opportunities
Disease area: Airway diseases



Rating:

Share or cite this content

Citations should be made in the following way:
Y. Feshchenko, L. Iashyna, S. Opimakh (Kiev, Ukraine). The influence of complex ICS/LABA therapy on oxygen consumption in COPD patients. Eur Respir J 2014; 44: Suppl. 58, 3400

Member's Comments

No comment yet.

Related content which might interest you: Prescribing patterns for UK patients commencing first maintenance therapy for COPD Source: International Congress 2014 – COPD markers Year: 2014 Hospital treatment costs of exacerbations in COPD patients with indications for LTOT Source: International Congress 2015 – Clinical assessment and monitoring of asthma and COPD Year: 2015 The parameters that may affect inhalation therapy success in elderly COPD and asthma patients Source: International Congress 2015 – Co-existing diseases and asthma Year: 2015 Effect of breathing parameters on lung dose in case of two combination drugs used in asthma and COPD therapy Source: International Congress 2016 – Pulmonary drug delivery Year: 2016 A pilot study of CPAP therapy for excessive dynamic airway collapse during acute exacerbation of COPD Source: International Congress 2014 – COPD - from biomarkers to novel therapeutic opportunities Year: 2014 CAT predicts mortality in COPD patients who require LTOT Source: International Congress 2016 – Biomarkers and phenotypes of COPD Year: 2016 Roflumilast added to triple therapy in severe COPD patients with frequent exacerbations: Efficacy and tolerability Source: International Congress 2014 – Markers Year: 2014 Inter-relationship of different types of respiratory symptoms in COPD Source: International Congress 2014 – Comorbidities Year: 2014 Characterising patterns of prescribing for UK COPD patients with comorbidities or history of pneumonia Source: International Congress 2014 – COPD exacerbations Year: 2014 Association between inhaled corticosteroid use in COPD and incidence or worsening of type2 diabetes Source: International Congress 2014 – Markers Year: 2014 Evolution of COPD patients with exertional desaturation treated with long term oxygen therapy during one year Source: International Congress 2014 – COPD physiopathology Year: 2014 Integrated care reduces hospital utilization among patients with severe COPD Source: International Congress 2014 – COPD exacerbations Year: 2014 Effects of aclidinium bromide/formoterol fumarate fixed-dose combination on health status in COPD Source: International Congress 2014 – COPD markers Year: 2014 Do patients with moderate hypoxemia require LTOT? Source: International Congress 2016 – Long-term oxygen therapy, noninvasive ventilation, and other clinical variables in chronic lung diseases Year: 2016 Effect of exacerbation history and ICS use on outcomes in COPD patients from the TIOSPIR™ trial Source: International Congress 2015 – New data on established treatments for COPD Year: 2015 COPD on anti-GERD therapy remains at higher risk for severe exacerbation Source: International Congress 2014 – COPD exacerbations Year: 2014 COPD: Influence of patients’ nutritive status on the exacerbations rate Source: International Congress 2016 – COPD diagnosis and management Year: 2016 Mukoregulatory drugs in treating COPD Source: International Congress 2014 – Predictors Year: 2014 Number of exacerbations in COPD patients treated with nasal high flow heated and humidified oxygen Source: International Congress 2014 – COPD markers Year: 2014 The use of long term home oxygen therapy reduces hospitalizations and mortality in COPD patients Source: International Congress 2014 – Clinical assessment of airway diseases Year: 2014